Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 58 (4), 406-8

Bone Marrow Biopsy Morbidity: Review of 2003


Bone Marrow Biopsy Morbidity: Review of 2003

B J Bain. J Clin Pathol.


Background: Although some hazards are recognised, in general, bone marrow aspiration and trephine biopsy are thought to be safe procedures. Until recently, no attempt had been made to quantify any attendant risks. For this reason, documentation of adverse events was begun in 2001, under the auspices of the British Society for Haematology. Three consecutive years have now been surveyed, the results for 2003 being presented here and compared with earlier results.

Methods: Members of the British Society of Haematology were requested to document adverse events associated with diagnostic bone marrow aspirates and trephine biopsies between 1 January and 31 December, 2003. Data were collected early in 2004.

Results: In total, 19,259 procedures were reported from 63 hospitals, 13,147 being combined procedures and 6112 aspirates without a trephine biopsy. Sixteen adverse events were reported, representing 0.08% of total reported procedures. The major adverse event was haemorrhage, which comprised 11 of the 16 adverse events. Although infrequent, adverse events were associated with significant morbidity and three were judged as very serious. The major risk factors for haemorrhage, in order of frequency, were diagnosis of a myeloproliferative disorder, aspirin treatment, other putative platelet dysfunctions, and thrombocytopenia.

Conclusions: Adverse events following trephine biopsies and bone marrow aspirates are rare, but nevertheless can have considerable impact on individual patients.

Similar articles

  • A Review of Histology of Bone Marrow Trephine in Malignant Lymphomas
    MA Durosinmi et al. Niger J Med 12 (4), 198-201. PMID 14768193.
    Bone marrow examination is an important aspect in the diagnosis of patients with malignant lymphoma and there is superiority of trephine biopsy over the aspiration biopsy …
  • Bone Marrow Biopsy Morbidity and Mortality: 2002 Data
    BJ Bain. Clin Lab Haematol 26 (5), 315-8. PMID 15485459.
    A survey of morbidity and mortality of bone marrow aspiration and trephine biopsy was carried out for the British Society of Haematology, covering the 12 months of 2002. …
  • Bone Marrow Biopsy Morbidity and Mortality
    BJ Bain. Br J Haematol 121 (6), 949-51. PMID 12786808.
    A postal survey of adverse events associated with bone marrow biopsy (aspiration biopsy with or without trephine biopsy) was carried out among British Society of Haematol …
  • [Collection of Hematopoietic Progenitor Cells From Healthy Donors]
    I Bojanić et al. Acta Med Croatica 63 (3), 237-44. PMID 19827352. - Review
    Allogeneic hematopoietic progenitor cell (HPC) transplantation is an established therapy for many hematologic disorders. HPCs may be collected from bone marrow, periphera …
  • [Indications for Bone Marrow Biopsy in Adults]
    AM van Marion et al. Ned Tijdschr Geneeskd 149 (6), 283-8. PMID 15730034. - Review
    Bone marrow biopsies are more and more often part of the work-up of patients with haematological disorders. The most important reason for this is the fact that a biopsy s …
See all similar articles

Cited by 21 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources